Viveve Medical (VIVE) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VIVE vs. NMRD, UTRS, MOTS, DRTSW, ANZUW, ATAKW, BBLGW, GMVDW, HSCSW, and BEATWShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Its Competitors Nemaura Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics G Medical Innovations Heart Test Laboratories HeartBeam Nemaura Medical (NASDAQ:NMRD) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability. Which has more risk and volatility, NMRD or VIVE? Nemaura Medical has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500. Is NMRD or VIVE more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Viveve Medical N/A N/A N/A Which has stronger valuation & earnings, NMRD or VIVE? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K0.00-$14.14M-$0.39N/AViveve Medical$6.83M0.00N/AN/AN/A Do institutionals & insiders hold more shares of NMRD or VIVE? 4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 5.7% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer NMRD or VIVE? In the previous week, Nemaura Medical had 1 more articles in the media than Viveve Medical. MarketBeat recorded 1 mentions for Nemaura Medical and 0 mentions for Viveve Medical. Nemaura Medical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Viveve Medical Neutral SummaryNemaura Medical beats Viveve Medical on 4 of the 5 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$33.45M$5.48B$9.53BDividend YieldN/AN/A4.73%4.09%P/E RatioN/A3.0528.8923.83Price / SalesN/A198.51371.1466.13Price / CashN/A41.3635.4557.96Price / BookN/A1.788.265.54Net IncomeN/A-$2.66M$3.25B$259.28M Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/AN/AN/A-75.0%$1K$6.83M0.0070NMRDNemaura Medical0.9142 of 5 stars$0.00flatN/A-99.7%$4K$3.02K0.0040High Trading VolumeUTRSMinerva SurgicalN/A$0.00flatN/AN/A$1K$51.69M0.00160MOTSMotus GIN/A$0.00flatN/A-99.8%$1K$319K0.0030High Trading VolumeDRTSWAlpha Tau MedicalN/A$0.24-11.9%N/A+35.6%$0.00N/A0.0080Positive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.06+8.2%N/A-9.8%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02-25.0%N/A-51.7%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$15.00+11.1%N/AN/A$0.00N/A0.002Positive NewsGMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.16+23.7%N/A+101.7%$0.00N/A0.0010Positive NewsGap DownBEATWHeartBeamN/A$0.28+0.0%N/A-33.3%$0.00N/A0.005Positive NewsGap Down Related Companies and Tools Related Companies Nemaura Medical Competitors Minerva Surgical Competitors Motus GI Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors G Medical Innovations Competitors Heart Test Laboratories Competitors HeartBeam Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
